BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 23, 2006
View Archived Issues
Tanabe Seiyaku presents clinical highlights of past year
Read More
Nilotinib highlights from ASCO 2006
Read More
Recent data from lapatinib clinical trials presented
Read More
MBP-8298 delays multiple sclerosis progression in HLA class II subgroup
Read More
Analysis correlates efaproxiral concentrations with clinical benefit
Read More
Takara Bio to jointly develop AIDS gene therapy with China institute
Read More
Pivotal study of rhThrombin completes enrollment
Read More
IMPACT studies of OvaRex complete enrollment
Read More
Trials further reveal indiplon efficacy and safety in patients with insomnia
Read More
Effects of CX-717 on EEG spectra assessed after sleep deprivation
Read More
Novel histamine H1 agonist as a clinical candidate for sleep maintenance insomnia
Read More
VEC-162: rapidly shifts circadian phases to improve sleep properties
Read More
Roche and Evotec partner in CNS drug discovery and development
Read More
T-5224 enters phase I in Japan for rheumatoid arthritis
Read More
rEV-131 studied in new trial for inflammation following cataract surgery
Read More
SkyePharma reviews pipeline development
Read More
Schering AG acquires Celera Genomics' cathepsin S inhibitor program
Read More
Lundbeck to advance Lu-AA21004 for depression
Read More
CTCE-0214 to be studied for repopulating blood stem cell
Read More
Athenagen to begin phase I/II study of wound healing agent ATG-002
Read More
AEterna Zentaris to advance cetrorelix into phase III for BPH
Read More
NDA submission for Cyanokit for cyanide poisoning
Read More
Orphan drug designation for MORAb-003 in ovarian cancer
Read More
EMEA recommends orphan drug designation for GV-1001 in pancreatic cancer
Read More
European approval of Acomplia
Read More
Arginase: a novel target for diabetes
Read More
Inhibition of hepatic micro RNA regulates lipid metabolism in vivo
Read More
Novel treatment options for metabolic disorders described in recent patents
Read More
Novel agents for cardiovascular disorders disclosed
Read More
Recent patents describe therapeutic agents for respiratory disorders
Read More
